The Ibogaine Newsletter
New research the moment it’s published, legal status changes by country, and newly verified treatment centers, sent straight to your inbox. No spam, unsubscribe anytime.
What You’ll Actually Get
This isn’t a marketing list for any particular clinic. We built this newsletter the same way we built the rest of the site: independent, source-linked, and focused on what actually changed, not recycled content. Most of that comes straight out of our own blog, which is the actual backbone of this site’s original reporting, not an afterthought bolted onto a directory.
This is where most of what makes this site useful actually lives. When we publish a new deep-dive, like a mechanism explainer, a cost breakdown, or a myth we think needs correcting, from our library of 35 articles, you’ll be the first to know, not someone who stumbles on it months later.
Browse the blog →Plain-English summaries of new ibogaine studies as they’re published, pulled from our database of 692 tracked papers, with links to the original source every time.
Browse the research →When a country’s legal status actually changes, like Texas’s 2025 HB 3927 funding FDA-track clinical trials, we tell you before it’s old news.
See legality by country →New treatment centers get added to our directory after passing our 7-criteria safety review. We let you know when one does, with no sponsored placement.
Browse centers →Ready to Subscribe?
Free. No spam. Unsubscribe anytime.